XML 30 R18.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Fair Value of Financial Instruments | 9 Months Ended
--- | ---
Sep. 30, 2017
Fair Value of Financial Instruments [Abstract] |
Fair Value of Financial Instruments | 12. Fair Value of Financial Instruments ﻿ The carrying values and estimated fair values of our financial instruments (in millions) were as follows: ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿ | As of September 30, 2017 |  | As of December 31, 2016 |
﻿ | Carrying |  | Fair |  | Carrying |  | Fair |
﻿ | Value |  | Value |  | Value |  | Value |
﻿Assets |  |  |  |  |  |  |  |  |  |  |  |
﻿AFS securities: |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity securities | $ | 93,767 |  | $ | 93,767 |  | $ | 89,013 |  | $ | 89,013 |
﻿VIEs’ fixed maturity securities |  | - |  |  | - |  |  | 200 |  |  | 200 |
﻿Equity securities |  | 302 |  |  | 302 |  |  | 275 |  |  | 275 |
﻿Trading securities |  | 1,665 |  |  | 1,665 |  |  | 1,712 |  |  | 1,712 |
﻿Mortgage loans on real estate |  | 10,382 |  |  | 10,487 |  |  | 9,889 |  |  | 9,853 |
﻿Derivative investments (1) |  | 960 |  |  | 960 |  |  | 927 |  |  | 927 |
﻿Other investments |  | 2,210 |  |  | 2,210 |  |  | 2,230 |  |  | 2,230 |
﻿Cash and invested cash |  | 1,965 |  |  | 1,965 |  |  | 2,722 |  |  | 2,722 |
﻿Other assets: |  |  |  |  |  |  |  |  |  |  |  |
﻿GLB direct embedded derivatives |  | 570 |  |  | 570 |  |  | - |  |  | - |
﻿GLB ceded embedded derivatives |  | 53 |  |  | 53 |  |  | 203 |  |  | 203 |
﻿Indexed annuity ceded embedded derivatives |  | 3 |  |  | 3 |  |  | - |  |  | - |
﻿Separate account assets |  | 139,612 |  |  | 139,612 |  |  | 128,397 |  |  | 128,397 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿Liabilities |  |  |  |  |  |  |  |  |  |  |  |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives |  | (1,318 | ) |  | (1,318 | ) |  | (1,139 | ) |  | (1,139 | )
﻿Other contract holder funds: |  |  |  |  |  |  |  |  |  |  |  |
﻿Remaining guaranteed interest and similar contracts |  | (612 | ) |  | (612 | ) |  | (629 | ) |  | (629 | )
﻿Account values of certain investment contracts |  | (32,089 | ) |  | (36,281 | ) |  | (31,516 | ) |  | (35,647 | )
﻿Short-term debt |  | (450 | ) |  | (453 | ) |  | - |  |  | - |
﻿Long-term debt |  | (4,900 | ) |  | (5,455 | ) |  | (5,345 | ) |  | (5,679 | )
﻿Reinsurance related embedded derivatives |  | (63 | ) |  | (63 | ) |  | (53 | ) |  | (53 | )
﻿Other liabilities: |  |  |  |  |  |  |  |  |  |  |  |
﻿Derivative liabilities (1) |  | (213 | ) |  | (213 | ) |  | (553 | ) |  | (553 | )
﻿GLB direct embedded derivatives |  | - |  |  | - |  |  | (371 | ) |  | (371 | )
﻿GLB ceded embedded derivatives |  | (7 | ) |  | (7 | ) |  | - |  |  | - |
﻿
| (1) |  | We have master netting agreements with each of our derivative counterparties, which allow for the netting of our derivative asset and liability positions by counterparty.
﻿ Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value ﻿ The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value on our Consolidated Balance Sheets. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments. ﻿ Mortgage Loans on Real Estate ﻿ The fair value of mortgage loans on real estate is established using a discounted cash flow method based on credit rating, maturity and future income. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt-service coverage, loan-to-value, quality of tenancy, borrower and payment record. The fair value for impaired mortgage loans is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price or the fair value of the collateral if the loan is collateral dependent. The inputs used to measure the fair value of our mortgage loans on real estate are classified as Level 2 within the fair value hierarchy. ﻿ Other Investments ﻿ The carrying value of our assets classified as other investments approximates fair value. Other investments includes primarily LPs and other privately held investments that are accounted for using the equity method of accounting and the carrying value is based on our proportional share of the net assets of the LPs. The inputs used to measure the fair value of our LPs and other privately held investments are classified as Level 3 within the fair value hierarchy. Other investments also includes securities that are not LPs or other privately held investments and the inputs used to measure the fair value of these securities are classified as Level 1 within the fair value hierarchy. ﻿ Other Contract Holder Funds ﻿ Other contract holder funds include remaining guaranteed interest and similar contracts and account values of certain investment contracts. The fair value for the remaining guaranteed interest and similar contracts is estimated using discounted cash flow calculations as of the balance sheet date. These calculations are based on interest rates currently offered on similar contracts with maturities that are consist ent with those remaining for the contracts being valued. As of September 30, 2017, and December 31, 2016, the r emaining guaranteed interest and similar contracts carrying value approximated fair value. The fair value of the account values of certain investment contracts is based on their approximate surrender value as of the balance sheet date. The inputs used to measure the fair value of our other contract holder funds are classified as Level 3 within the fair value hierarchy. ﻿ Short-Term and Long-Term Debt ﻿ The fair value of short-term and long-term debt is based on quoted market prices. The inputs used to measure the fair value of our short-term and long-term debt are classified as Level 2 within the fair value hierarchy. ﻿ Financial Instruments Carried at Fair Value ﻿ We did not have any assets or liabilities measured at fair valu e on a nonrecurring basis as of September 30, 2017, o r December 31, 2016, and we noted no changes in our valuation methodologies between these periods. ﻿ The following summarizes our financial instruments carried at fair value (in millions) on a recurring basis by the fair value hierarchy levels described in “Summary of Significant Accounting Policies” in Note 1 of our 20 16 Fo rm 10-K: ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | As of September 30, 2017 |
﻿ |  | Quoted |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | Prices |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | in Active |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | Markets for | Significant | Significant |  |  |  |
﻿ |  | Identical |  | Observable | Unobservable |  | Total |
﻿ |  | Assets |  |  | Inputs |  |  | Inputs |  |  | Fair |
﻿ |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | Value |
﻿Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds |  | $ | - |  |  | $ | 78,721 |  |  | $ | 2,580 |  |  | $ | 81,301 |
﻿ABS |  |  | - |  |  |  | 991 |  |  |  | 27 |  |  |  | 1,018 |
﻿U.S. government bonds |  |  | 562 |  |  |  | 7 |  |  |  | 5 |  |  |  | 574 |
﻿Foreign government bonds |  |  | - |  |  |  | 345 |  |  |  | 110 |  |  |  | 455 |
﻿RMBS |  |  | - |  |  |  | 3,481 |  |  |  | 13 |  |  |  | 3,494 |
﻿CMBS |  |  | - |  |  |  | 537 |  |  |  | 6 |  |  |  | 543 |
﻿CLOs |  |  | - |  |  |  | 679 |  |  |  | 15 |  |  |  | 694 |
﻿State and municipal bonds |  |  | - |  |  |  | 5,049 |  |  |  | - |  |  |  | 5,049 |
﻿Hybrid and redeemable preferred securities |  |  | 70 |  |  |  | 493 |  |  |  | 76 |  |  |  | 639 |
﻿Equity AFS securities |  |  | 32 |  |  |  | 80 |  |  |  | 190 |  |  |  | 302 |
﻿Trading securities |  |  | 73 |  |  |  | 1,542 |  |  |  | 50 |  |  |  | 1,665 |
﻿Derivative investments (1) |  |  | - |  |  |  | 1,119 |  |  |  | 564 |  |  |  | 1,683 |
﻿Other investments |  |  | 150 |  |  |  | - |  |  |  | - |  |  |  | 150 |
﻿Cash and invested cash |  |  | - |  |  |  | 1,965 |  |  |  | - |  |  |  | 1,965 |
﻿Other assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿GLB direct embedded derivatives |  |  | - |  |  |  | - |  |  |  | 570 |  |  |  | 570 |
﻿GLB ceded embedded derivatives |  |  | - |  |  |  | - |  |  |  | 53 |  |  |  | 53 |
﻿Indexed annuity ceded embedded derivatives |  |  | - |  |  |  | - |  |  |  | 3 |  |  |  | 3 |
﻿Separate account assets |  |  | 824 |  |  |  | 138,788 |  |  |  | - |  |  |  | 139,612 |
﻿Total assets |  | $ | 1,711 |  |  | $ | 233,797 |  |  | $ | 4,262 |  |  | $ | 239,770 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives |  | $ | - |  |  | $ | - |  |  | $ | (1,318 | ) |  | $ | (1,318 | )
﻿Long-term debt |  |  | - |  |  |  | (1,134 | ) |  |  | - |  |  |  | (1,134 | )
﻿Reinsurance related embedded derivatives |  |  | - |  |  |  | (63 | ) |  |  | - |  |  |  | (63 | )
﻿Other liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Derivative liabilities (1) |  |  | - |  |  |  | (438 | ) |  |  | (498 | ) |  |  | (936 | )
﻿GLB ceded embedded derivatives |  |  | - |  |  |  | - |  |  |  | (7 | ) |  |  | (7 | )
﻿Total liabilities |  | $ | - |  |  | $ | (1,635 | ) |  | $ | (1,823 | ) |  | $ | (3,458 | )
﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | As of December 31, 2016 |
﻿ |  | Quoted |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | Prices |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  | in Active |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | Markets for | Significant | Significant |  |  |  |
﻿ |  | Identical |  | Observable | Unobservable |  | Total |
﻿ |  | Assets |  |  | Inputs |  |  | Inputs |  |  | Fair |
﻿ |  | (Level 1) |  |  | (Level 2) |  |  | (Level 3) |  |  | Value |
﻿Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds |  | $ | - |  |  | $ | 74,659 |  |  | $ | 2,405 |  |  | $ | 77,064 |
﻿ABS |  |  | - |  |  |  | 1,052 |  |  |  | 33 |  |  |  | 1,085 |
﻿U.S. government bonds |  |  | 408 |  |  |  | 11 |  |  |  | - |  |  |  | 419 |
﻿Foreign government bonds |  |  | - |  |  |  | 395 |  |  |  | 111 |  |  |  | 506 |
﻿RMBS |  |  | - |  |  |  | 3,611 |  |  |  | 3 |  |  |  | 3,614 |
﻿CMBS |  |  | - |  |  |  | 343 |  |  |  | 7 |  |  |  | 350 |
﻿CLOs |  |  | - |  |  |  | 676 |  |  |  | 68 |  |  |  | 744 |
﻿State and municipal bonds |  |  | - |  |  |  | 4,627 |  |  |  | - |  |  |  | 4,627 |
﻿Hybrid and redeemable preferred securities |  |  | 60 |  |  |  | 468 |  |  |  | 76 |  |  |  | 604 |
﻿VIEs’ fixed maturity securities |  |  | - |  |  |  | 200 |  |  |  | - |  |  |  | 200 |
﻿Equity AFS securities |  |  | 17 |  |  |  | 81 |  |  |  | 177 |  |  |  | 275 |
﻿Trading securities |  |  | 102 |  |  |  | 1,545 |  |  |  | 65 |  |  |  | 1,712 |
﻿Derivative investments (1) |  |  | - |  |  |  | 1,406 |  |  |  | 599 |  |  |  | 2,005 |
﻿Other investments |  |  | 146 |  |  |  | - |  |  |  | - |  |  |  | 146 |
﻿Cash and invested cash |  |  | - |  |  |  | 2,722 |  |  |  | - |  |  |  | 2,722 |
﻿Other assets – GLB ceded embedded derivatives |  |  | - |  |  |  | - |  |  |  | 203 |  |  |  | 203 |
﻿Separate account assets |  |  | 863 |  |  |  | 127,534 |  |  |  | - |  |  |  | 128,397 |
﻿Total assets |  | $ | 1,596 |  |  | $ | 219,330 |  |  | $ | 3,747 |  |  | $ | 224,673 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ and IUL contracts embedded derivatives |  | $ | - |  |  | $ | - |  |  | $ | (1,139 | ) |  | $ | (1,139 | )
﻿Long-term debt |  |  | - |  |  |  | (1,203 | ) |  |  | - |  |  |  | (1,203 | )
﻿Reinsurance related embedded derivatives |  |  | - |  |  |  | (53 | ) |  |  | - |  |  |  | (53 | )
﻿Other liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Derivative liabilities (1) |  |  | - |  |  |  | (939 | ) |  |  | (692 | ) |  |  | (1,631 | )
﻿GLB direct embedded derivatives |  |  | - |  |  |  | - |  |  |  | (371 | ) |  |  | (371 | )
﻿Total liabilities |  | $ | - |  |  | $ | (2,195 | ) |  | $ | (2,202 | ) |  | $ | (4,397 | )
﻿
| (1) |  | Derivative investment assets and liabilities presented within the fair value hierarchy are presented on a gross basis by derivative type and not on a master netting basis by counterparty.
The following summarizes changes to our financial instruments carried at fair value (in millions) and classified within Level 3 of the fair value hierarchy. This summary excludes any effect of amortization of deferred acquisition costs (“DAC”), value of business acquired (“VOBA”), deferred sales inducements (“DSI”) and deferred front-end loads (“DFEL”). The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. ﻿ ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Three Months Ended September 30, 2017 |
﻿ |  |  |  |  |  |  | Gains | Issuances, | Transfers |  |  |  |
﻿ |  |  |  | Items |  | (Losses) |  | Sales, |  | Into or |  |  |  |
﻿ |  |  |  | Included |  | in | Maturities, | Out |  |  |  |
﻿ | Beginning |  | in |  | OCI | Settlements, | of |  | Ending |
﻿ | Fair |  | Net |  | and |  | Calls, |  | Level 3, |  | Fair |
﻿ | Value |  | Income |  | Other (1) |  | Net |  | Net (2) |  | Value |
﻿Investments: (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 2,517 |  | $ | 4 |  | $ | 35 |  | $ | (35 | ) | $ | 59 |  | $ | 2,580 |
﻿ABS |  | 43 |  |  | - |  |  | (1 | ) |  | - |  |  | (15 | ) |  | 27 |
﻿U.S. government bonds |  | 5 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 5 |
﻿Foreign government bonds |  | 109 |  |  | - |  |  | 1 |  |  | - |  |  | - |  |  | 110 |
﻿RMBS |  | 7 |  |  | - |  |  | - |  |  | 6 |  |  | - |  |  | 13 |
﻿CMBS |  | 21 |  |  | - |  |  | - |  |  | (1 | ) |  | (14 | ) |  | 6 |
﻿CLOs |  | 28 |  |  | - |  |  | - |  |  | 15 |  |  | (28 | ) |  | 15 |
﻿Hybrid and redeemable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿preferred securities |  | 82 |  |  | - |  |  | 3 |  |  | - |  |  | (9 | ) |  | 76 |
﻿Equity AFS securities |  | 183 |  |  | - |  |  | (1 | ) |  | 9 |  |  | (1 | ) |  | 190 |
﻿Trading securities |  | 59 |  |  | - |  |  | - |  |  | (10 | ) |  | 1 |  |  | 50 |
﻿Derivative investments |  | 155 |  |  | (13 | ) |  | 9 |  |  | (85 | ) |  | - |  |  | 66 |
﻿Other assets: (5) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿GLB direct embedded derivatives |  | 298 |  |  | 272 |  |  | - |  |  | - |  |  | - |  |  | 570 |
﻿GLB ceded embedded derivatives |  | 85 |  |  | (32 | ) |  | - |  |  | - |  |  | - |  |  | 53 |
﻿Indexed annuity ceded embedded derivatives |  | - |  |  | - |  |  | - |  |  | 3 |  |  | - |  |  | 3 |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives (5) |  | (1,268 | ) |  | (47 | ) |  | - |  |  | (3 | ) |  | - |  |  | (1,318 | )
﻿Other liabilities – GLB ceded embedded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿derivatives (5) |  | - |  |  | (7 | ) |  | - |  |  | - |  |  | - |  |  | (7 | )
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Total, net | $ | 2,324 |  | $ | 177 |  | $ | 46 |  | $ | (101 | ) | $ | (7 | ) | $ | 2,439 |
﻿ ﻿ ﻿ ﻿ ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Three Months Ended September 30, 2016 |
﻿ |  |  |  |  |  |  | Gains | Issuances, | Transfers |  |  |  |
﻿ |  |  |  | Items |  | (Losses) |  | Sales |  | Into or |  |  |  |
﻿ |  |  |  | Included |  | in | Maturities, | Out |  |  |  |
﻿ | Beginning |  | in |  | OCI | Settlements, | of |  | Ending |
﻿ | Fair |  | Net |  | and |  | Calls, |  | Level 3, |  | Fair |
﻿ | Value |  | Income |  | Other (1) |  | Net |  | Net (2) |  | Value |
﻿Investments: (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 2,425 |  | $ | (1 | ) | $ | 15 |  | $ | (74 | ) | $ | 66 |  | $ | 2,431 |
﻿ABS |  | 62 |  |  | - |  |  | - |  |  | - |  |  | (27 | ) |  | 35 |
﻿U.S. government bonds |  | 10 |  |  | - |  |  | - |  |  | (2 | ) |  | - |  |  | 8 |
﻿Foreign government bonds |  | 112 |  |  | - |  |  | 1 |  |  | - |  |  | - |  |  | 113 |
﻿RMBS |  | 16 |  |  | - |  |  | - |  |  | 51 |  |  | (13 | ) |  | 54 |
﻿CMBS |  | 8 |  |  | - |  |  | - |  |  | 30 |  |  | - |  |  | 38 |
﻿CLOs |  | 45 |  |  | - |  |  | (1 | ) |  | 35 |  |  | (5 | ) |  | 74 |
﻿Hybrid and redeemable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿preferred securities |  | 89 |  |  | - |  |  | (1 | ) |  | - |  |  | - |  |  | 88 |
﻿Equity AFS securities |  | 170 |  |  | 3 |  |  | (6 | ) |  | (4 | ) |  | - |  |  | 163 |
﻿Trading securities |  | 65 |  |  | 1 |  |  | 4 |  |  | 6 |  |  | - |  |  | 76 |
﻿Derivative investments |  | 423 |  |  | (89 | ) |  | (1 | ) |  | (69 | ) |  | - |  |  | 264 |
﻿Other investments (4) |  | 1 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 1 |
﻿Other assets – GLB ceded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives (5) |  | 539 |  |  | (65 | ) |  | - |  |  | - |  |  | - |  |  | 474 |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿derivatives (5) |  | (1,102 | ) |  | (64 | ) |  | - |  |  | 41 |  |  | - |  |  | (1,125 | )
﻿Other liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Credit default swaps (4) |  | (16 | ) |  | 1 |  |  | - |  |  | 15 |  |  | - |  |  | - |
﻿GLB direct embedded derivatives (5) |  | (2,458 | ) |  | 581 |  |  | - |  |  | - |  |  | - |  |  | (1,877 | )
﻿Total, net | $ | 389 |  | $ | 367 |  | $ | 11 |  | $ | 29 |  | $ | 21 |  | $ | 817 |
﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Nine Months Ended September 30, 2017 |
﻿ |  |  |  |  |  |  | Gains | Issuances, | Transfers |  |  |  |
﻿ |  |  |  | Items |  | (Losses) | Sales, | Into or |  |  |  |
﻿ |  |  |  | Included |  | in | Maturities, | Out |  |  |  |
﻿ | Beginning |  | in |  | OCI | Settlements, | of |  | Ending |
﻿ | Fair |  | Net |  | and |  | Calls, |  | Level 3, |  | Fair |
﻿ | Value |  | Income |  | Other (1) |  | Net |  | Net (2) |  | Value |
﻿Investments: (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 2,405 |  | $ | 15 |  | $ | 153 |  | $ | (182 | ) | $ | 189 |  | $ | 2,580 |
﻿ABS |  | 33 |  |  | - |  |  | - |  |  | - |  |  | (6 | ) |  | 27 |
﻿U.S. government bonds |  | - |  |  | - |  |  | - |  |  | - |  |  | 5 |  |  | 5 |
﻿Foreign government bonds |  | 111 |  |  | - |  |  | (1 | ) |  | - |  |  | - |  |  | 110 |
﻿RMBS |  | 3 |  |  | - |  |  | - |  |  | 10 |  |  | - |  |  | 13 |
﻿CMBS |  | 7 |  |  | - |  |  | 1 |  |  | 54 |  |  | (56 | ) |  | 6 |
﻿CLOs |  | 68 |  |  | - |  |  | - |  |  | 33 |  |  | (86 | ) |  | 15 |
﻿State and municipal bonds |  | - |  |  | (1 | ) |  | - |  |  | - |  |  | 1 |  |  | - |
﻿Hybrid and redeemable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿preferred securities |  | 76 |  |  | - |  |  | 14 |  |  | - |  |  | (14 | ) |  | 76 |
﻿Equity AFS securities |  | 177 |  |  | 1 |  |  | (2 | ) |  | 15 |  |  | (1 | ) |  | 190 |
﻿Trading securities |  | 65 |  |  | 2 |  |  | 8 |  |  | (26 | ) |  | 1 |  |  | 50 |
﻿Derivative investments |  | (93 | ) |  | (25 | ) |  | 97 |  |  | 87 |  |  | - |  |  | 66 |
﻿Other assets: (5) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿GLB direct embedded derivatives |  | - |  |  | 570 |  |  | - |  |  | - |  |  | - |  |  | 570 |
﻿GLB ceded embedded derivatives |  | 203 |  |  | (150 | ) |  | - |  |  | - |  |  | - |  |  | 53 |
﻿Indexed annuity ceded embedded derivatives |  | - |  |  | - |  |  | - |  |  | 3 |  |  | - |  |  | 3 |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives (5) |  | (1,139 | ) |  | (230 | ) |  | - |  |  | 51 |  |  | - |  |  | (1,318 | )
﻿Other liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿GLB direct embedded derivatives (5) |  | (371 | ) |  | 371 |  |  | - |  |  | - |  |  | - |  |  | - |
﻿GLB ceded embedded derivatives (5) |  |  |  |  | (7 | ) |  | - |  |  | - |  |  | - |  |  | (7 | )
﻿Total, net | $ | 1,545 |  | $ | 546 |  | $ | 270 |  | $ | 45 |  | $ | 33 |  | $ | 2,439 |
﻿ ﻿ ﻿ ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Nine Months Ended September 30, 2016 |
﻿ |  |  |  |  |  |  | Gains | Issuances, | Transfers |  |  |  |
﻿ |  |  |  | Items |  | (Losses) | Sales, | Into or |  |  |  |
﻿ |  |  |  | Included |  | in | Maturities, | Out |  |  |  |
﻿ | Beginning |  | in |  | OCI | Settlements, | of |  | Ending |
﻿ | Fair |  | Net |  | and |  | Calls, |  | Level 3, |  | Fair |
﻿ | Value |  | Income |  | Other (1) |  | Net |  | Net (2) |  | Value |
﻿Investments: (3) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 1,993 |  | $ | (1 | ) | $ | 79 |  | $ | 72 |  | $ | 288 |  | $ | 2,431 |
﻿ABS |  | 45 |  |  | - |  |  | (1 | ) |  | 14 |  |  | (23 | ) |  | 35 |
﻿U.S. government bonds |  | - |  |  | - |  |  | - |  |  | 8 |  |  | - |  |  | 8 |
﻿Foreign government bonds |  | 111 |  |  | - |  |  | 2 |  |  | - |  |  | - |  |  | 113 |
﻿RMBS |  | 1 |  |  | - |  |  | - |  |  | 66 |  |  | (13 | ) |  | 54 |
﻿CMBS |  | 10 |  |  | 2 |  |  | (1 | ) |  | 27 |  |  | - |  |  | 38 |
﻿CLOs |  | 551 |  |  | - |  |  | 1 |  |  | 113 |  |  | (591 | ) |  | 74 |
﻿Hybrid and redeemable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿preferred securities |  | 94 |  |  | - |  |  | (6 | ) |  | - |  |  | - |  |  | 88 |
﻿Equity AFS securities |  | 164 |  |  | 3 |  |  | (4 | ) |  | - |  |  | - |  |  | 163 |
﻿Trading securities |  | 73 |  |  | 3 |  |  | 5 |  |  | 5 |  |  | (10 | ) |  | 76 |
﻿Derivative investments |  | 555 |  |  | (346 | ) |  | 170 |  |  | (115 | ) |  | - |  |  | 264 |
﻿Other investments (4) |  | - |  |  | 1 |  |  | - |  |  | - |  |  | - |  |  | 1 |
﻿Other assets – GLB ceded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives (5) |  | 268 |  |  | 206 |  |  | - |  |  | - |  |  | - |  |  | 474 |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives (5) |  | (1,100 | ) |  | (76 | ) |  | - |  |  | 51 |  |  | - |  |  | (1,125 | )
﻿VIEs’ liabilities – derivative instruments (5) |  | (4 | ) |  | 4 |  |  | - |  |  | - |  |  | - |  |  | - |
﻿Other liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Credit default swaps (4) |  | (9 | ) |  | (6 | ) |  | - |  |  | 15 |  |  | - |  |  | - |
﻿GLB direct embedded derivatives (5) |  | (953 | ) |  | (924 | ) |  | - |  |  | - |  |  | - |  |  | (1,877 | )
﻿Total, net | $ | 1,799 |  | $ | (1,134 | ) | $ | 245 |  | $ | 256 |  | $ | (349 | ) | $ | 817 |
﻿
| (1) |  | The changes in fair value of the interest rate swaps are offset by an adjustment to derivative investments (see Note 5).
| (2) |  | Transfers into or out of Level 3 for AFS and trading securities are displayed at amortized cost as of the beginning-of-period. For AFS and trading securities, the diff erence between beginning-of-period amor tized cost and beginning-of-period fair value was included in OCI and earnings, respectively, in the prior period.
| (3) |  | Amortization and accretion of premiums and discounts are included in net investment income on our Consolidated Statements of Comprehensive Income (Loss). Gains (losses) from sales, maturities, settlements and calls and OTTI are included in realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
| (4) |  | The changes in fair value of the credit default swaps and contingency forwards are included in realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
| (5) |  | Gains (losses) from sales, maturities, settlements and calls are included in realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
﻿ The following provides the components of the items included in issuances, sales, maturities, settlements and calls, net, excluding any effect of amortization of DAC, VOBA, DSI and DFEL and changes in future contract benefits, (in millions) as reported above: ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Three Months Ended September 30, 2017 |
﻿ | Issuances |  | Sales |  | Maturities | Settlements | Calls |  | Total |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 167 |  | $ | (114 | ) | $ | (19 | ) | $ | (43 | ) | $ | (26 | ) | $ | (35 | )
﻿RMBS |  | 6 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 6 |
﻿CMBS |  | - |  |  | - |  |  | - |  |  | (1 | ) |  | - |  |  | (1 | )
﻿CLOs |  | 15 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 15 |
﻿Equity AFS securities |  | 10 |  |  | (1 | ) |  | - |  |  | - |  |  | - |  |  | 9 |
﻿Trading securities |  | - |  |  | (10 | ) |  | - |  |  | - |  |  | - |  |  | (10 | )
﻿Derivative investments |  | 50 |  |  | (23 | ) |  | (112 | ) |  | - |  |  | - |  |  | (85 | )
﻿Other assets – indexed annuity ceded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives |  | 3 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 3 |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives |  | (14 | ) |  | - |  |  | - |  |  | 11 |  |  | - |  |  | (3 | )
﻿Total, net | $ | 237 |  | $ | (148 | ) | $ | (131 | ) | $ | (33 | ) | $ | (26 | ) | $ | (101 | )
﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Three Months Ended September 30, 2016 |
﻿ | Issuances |  | Sales |  | Maturities | Settlements | Calls |  | Total |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 92 |  | $ | (20 | ) | $ | (18 | ) | $ | (50 | ) | $ | (78 | ) | $ | (74 | )
﻿U.S. government bonds |  | - |  |  | - |  |  | - |  |  | (2 | ) |  | - |  |  | (2 | )
﻿RMBS |  | 51 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 51 |
﻿CMBS |  | 31 |  |  | - |  |  | - |  |  | (1 | ) |  | - |  |  | 30 |
﻿CLOs |  | 35 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 35 |
﻿Equity AFS securities |  | - |  |  | (4 | ) |  | - |  |  | - |  |  | - |  |  | (4 | )
﻿Trading securities |  | 7 |  |  | - |  |  | - |  |  | (1 | ) |  | - |  |  | 6 |
﻿Derivative investments |  | 47 |  |  | (46 | ) |  | (70 | ) |  | - |  |  | - |  |  | (69 | )
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives |  | (13 | ) |  | - |  |  | - |  |  | 54 |  |  | - |  |  | 41 |
﻿Other liabilities – credit default swaps |  | - |  |  | 15 |  |  | - |  |  | - |  |  | - |  |  | 15 |
﻿Total, net | $ | 250 |  | $ | (55 | ) | $ | (88 | ) | $ | - |  | $ | (78 | ) | $ | 29 |
﻿ ﻿ ﻿ ﻿ ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Nine Months Ended September 30, 2017 |
﻿ | Issuances |  | Sales |  | Maturities | Settlements | Calls |  | Total |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 367 |  | $ | (179 | ) | $ | (66 | ) | $ | (170 | ) | $ | (134 | ) | $ | (182 | )
﻿RMBS |  | 10 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 10 |
﻿CMBS |  | 55 |  |  | - |  |  | - |  |  | (1 | ) |  | - |  |  | 54 |
﻿CLOs |  | 33 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 33 |
﻿Equity AFS securities |  | 18 |  |  | (3 | ) |  | - |  |  | - |  |  | - |  |  | 15 |
﻿Trading securities |  | 2 |  |  | (27 | ) |  | - |  |  | (1 | ) |  | - |  |  | (26 | )
﻿Derivative investments |  | 145 |  |  | 243 |  |  | (301 | ) |  | - |  |  | - |  |  | 87 |
﻿Other assets – indexed annuity ceded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives |  | 3 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 3 |
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives |  | (45 | ) |  | - |  |  | - |  |  | 96 |  |  | - |  |  | 51 |
﻿Total, net | $ | 588 |  | $ | 34 |  | $ | (367 | ) | $ | (76 | ) | $ | (134 | ) | $ | 45 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Nine Months Ended September 30, 2016 |
﻿ | Issuances |  | Sales |  | Maturities | Settlements | Calls |  | Total |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 381 |  | $ | (19 | ) | $ | (22 | ) | $ | (133 | ) | $ | (135 | ) | $ | 72 |
﻿ABS |  | 15 |  |  | - |  |  | - |  |  | (1 | ) |  | - |  |  | 14 |
﻿U.S. government bonds |  | - |  |  | - |  |  | - |  |  | 8 |  |  | - |  |  | 8 |
﻿RMBS |  | 66 |  |  | - |  |  | - |  |  | - |  |  | - |  |  | 66 |
﻿CMBS |  | 31 |  |  | (2 | ) |  | - |  |  | (2 | ) |  | - |  |  | 27 |
﻿CLOs |  | 115 |  |  | - |  |  | - |  |  | (2 | ) |  | - |  |  | 113 |
﻿Equity AFS securities |  | 4 |  |  | (4 | ) |  | - |  |  | - |  |  | - |  |  | - |
﻿Trading securities |  | 6 |  |  | - |  |  | - |  |  | (1 | ) |  | - |  |  | 5 |
﻿Derivative investments |  | 132 |  |  | (133 | ) |  | (114 | ) |  | - |  |  | - |  |  | (115 | )
﻿Future contract benefits – indexed annuity |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿and IUL contracts embedded derivatives |  | (58 | ) |  | - |  |  | - |  |  | 109 |  |  | - |  |  | 51 |
﻿Other liabilities – credit default swaps |  | - |  |  | 15 |  |  | - |  |  | - |  |  | - |  |  | 15 |
﻿Total, net | $ | 692 |  | $ | (143 | ) | $ | (136 | ) | $ | (22 | ) | $ | (135 | ) | $ | 256 |
﻿ The following summarizes changes in unrealized gains (losses) included in net income, excluding any effect of amortization of DAC, VOBA, DSI and DFEL and changes in future contract benefits, related to financial instruments carried at fair value classified within Level 3 that we still held (in millions): ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Three |  | For the Nine |  |
﻿ | Months Ended |  | Months Ended |  |
﻿ | September 30, |  | September 30, |  |
﻿ | 2017 |  | 2016 |  | 2017 |  | 2016 |  |
﻿Derivative investments | $ | (83 | ) | $ | (94 | ) | $ | (159 | ) | $ | (271 | ) |
﻿Other investments |  | - |  |  | - |  |  | - |  |  | 1 |  |
﻿Embedded derivatives: |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Indexed annuity and IUL contracts |  | 2 |  |  | (1 | ) |  | (13 | ) |  | (24 | ) |
﻿GLB |  | 428 |  |  | 712 |  |  | 1,352 |  |  | (521 | ) |
﻿VIEs’ liabilities – derivative instruments |  | - |  |  | - |  |  | - |  |  | 4 |  |
﻿Credit default swaps |  | - |  |  | 9 |  |  | - |  |  | 2 |  |
﻿Total, net (1) | $ | 347 |  | $ | 626 |  | $ | 1,180 |  | $ | (809 | ) |
﻿
| (1) |  | Included in realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
﻿ The following provides the components of the transfers into and out of Level 3 (in millions) as reported above: ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Three |  | For the Three |
﻿ | Months Ended |  | Months Ended |
﻿ | September 30, 2017 |  | September 30, 2016 |
﻿ | Transfers |  | Transfers |  |  |  |  | Transfers |  | Transfers |  |  |  |
﻿ | Into |  | Out of |  |  |  |  | Into |  | Out of |  |  |  |
﻿ | Level 3 |  | Level 3 |  | Total |  | Level 3 |  | Level 3 |  | Total |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 116 |  | $ | (57 | ) | $ | 59 |  | $ | 147 |  | $ | (81 | ) | $ | 66 |
﻿ABS |  | - |  |  | (15 | ) |  | (15 | ) |  | - |  |  | (27 | ) |  | (27 | )
﻿RMBS |  | - |  |  | - |  |  | - |  |  | 3 |  |  | (16 | ) |  | (13 | )
﻿CMBS |  | - |  |  | (14 | ) |  | (14 | ) |  | - |  |  | - |  |  | - |
﻿CLOs |  | - |  |  | (28 | ) |  | (28 | ) |  | - |  |  | (5 | ) |  | (5 | )
﻿Hybrid and redeemable preferred |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿securities |  | - |  |  | (9 | ) |  | (9 | ) |  | - |  |  | - |  |  | - |
﻿Equity AFS securities |  | - |  |  | (1 | ) |  | (1 | ) |  | - |  |  | - |  |  | - |
﻿Trading securities |  | 1 |  |  | - |  |  | 1 |  |  | - |  |  | - |  |  | - |
﻿Total, net | $ | 117 |  | $ | (124 | ) | $ | (7 | ) | $ | 150 |  | $ | (129 | ) | $ | 21 |
﻿ ﻿ ﻿ ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | For the Nine |  | For the Nine |
﻿ | Months Ended |  | Months Ended |
﻿ | September 30, 2017 |  | September 30, 2016 |
﻿ | Transfers |  | Transfers |  |  |  |  | Transfers |  | Transfers |  |  |  |
﻿ | Into |  | Out of |  |  |  |  | Into |  | Out of |  |  |  |
﻿ | Level 3 |  | Level 3 |  | Total |  | Level 3 |  | Level 3 |  | Total |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 277 |  | $ | (88 | ) | $ | 189 |  | $ | 476 |  | $ | (188 | ) | $ | 288 |
﻿ABS |  | 15 |  |  | (21 | ) |  | (6 | ) |  | 4 |  |  | (27 | ) |  | (23 | )
﻿U.S. government bonds |  | 5 |  |  | - |  |  | 5 |  |  | - |  |  | - |  |  | - |
﻿RMBS |  | - |  |  | - |  |  | - |  |  | 3 |  |  | (16 | ) |  | (13 | )
﻿CMBS |  | 3 |  |  | (59 | ) |  | (56 | ) |  | - |  |  | - |  |  | - |
﻿CLOs |  | 30 |  |  | (116 | ) |  | (86 | ) |  | - |  |  | (591 | ) |  | (591 | )
﻿State and municipal bonds |  | 2 |  |  | (1 | ) |  | 1 |  |  | - |  |  | - |  |  | - |
﻿Hybrid and redeemable preferred |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ securities |  | - |  |  | (14 | ) |  | (14 | ) |  | - |  |  | - |  |  | - |
﻿Equity AFS securities |  | - |  |  | (1 | ) |  | (1 | ) |  | - |  |  | - |  |  | - |
﻿Trading securities |  | 4 |  |  | (3 | ) |  | 1 |  |  | 1 |  |  | (11 | ) |  | (10 | )
﻿Total, net | $ | 336 |  | $ | (303 | ) | $ | 33 |  | $ | 484 |  | $ | (833 | ) | $ | (349 | )
﻿ Transfers into and out of Level 3 are generally the result of observable market information on a security no longer being available or becoming available to our pricing vendors. For the nine months ended September 30, 2017 and 201 6, transfers in and out of Level 3 were attributable primarily to the securities’ observable market information no longer being available or becoming available. Transfers into and out of Levels 1 and 2 are generally the result of a change in the type of input used to measure the fair value of an asset or liability at the end of the reporting period. When quoted prices in active markets become available, transfers from Level 2 to Level 1 will result. When quoted prices in active markets become unavailable, but we are able to employ a valuation methodology using significant observable inputs, transfers from Level 1 to Le vel 2 will result. For the nine months ended September 30, 2017 and 2016, the transfers between Levels 1 and 2 of the fair value hierarchy were less than $1 million for our financial instruments carried at fa ir value. The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of September 30, 2017: ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ | Fair |  | Valuation |  | Significant |  | Assumption or |
﻿ | Value |  | Technique |  | Unobservable Inputs |  | Input Ranges |
﻿Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Investments: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Fixed maturity AFS and trading |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Corporate bonds | $ | 2,008 |  | Discounted cash flow |  | Liquidity/duration adjustment (1) |  | 0.7 | % |  | - | 11.5 | % |
﻿ABS |  | 24 |  | Discounted cash flow |  | Liquidity/duration adjustment (1) |  | 3.0 | % |  | - | 3.0 | % |
﻿Foreign government bonds |  | 79 |  | Discounted cash flow |  | Liquidity/duration adjustment (1) |  | 1.7 | % |  | - | 3.4 | % |
﻿Hybrid and redeemable |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿preferred securities |  | 4 |  | Discounted cash flow |  | Liquidity/duration adjustment (1) |  | 1.9 | % |  | - | 1.9 | % |
﻿Equity AFS securities |  | 23 |  | Discounted cash flow |  | Liquidity/duration adjustment (1) |  | 4.5 | % |  | - | 4.9 | % |
﻿Other assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿GLB direct and ceded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives |  | 623 |  | Discounted cash flow |  | Long-term lapse rate (2) |  | 1 | % |  | - | 30 | % |
﻿ |  |  |  |  |  | Utilization of guaranteed withdrawals (3) | 85 | % |  | - | 100 | % |
﻿ |  |  |  |  |  |  | Claims utilization factor (4) |  | 60 | % |  | - | 100 | % |
﻿ |  |  |  |  |  |  | Premiums utilization factor (4) |  |  | 80 | % |  | - | 115 | % |
﻿ |  |  |  |  |  |  | NPR (5) |  |  | 0.01 | % |  | - | 0.27 | % |
﻿ |  |  |  |  |  |  | Mortality rate (6) |  |  |  |  |  |  | (8) |  |
﻿ |  |  |  |  |  |  | Volatility (7) |  | 1 | % |  | - | 29 | % |
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Indexed annuity ceded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives |  | 3 |  | Discounted cash flow |  | Lapse rate (2) |  | 0.4 | % |  | - | 9 | % |
﻿ |  |  |  |  |  |  | Mortality rate (6) |  |  |  |  |  | (8) |  |
﻿Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿Future contract benefits – indexed |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿annuity and IUL contracts |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives | $ | (1,318 | ) | Discounted cash flow |  | Lapse rate (2) |  | 0.4 | % |  | - | 9 | % |
﻿ |  |  |  |  |  |  | Mortality rate (6) |  |  |  |  |  | (8) |  |
﻿Other liabilities – GLB ceded |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿embedded derivatives |  | (7 | ) | Discounted cash flow |  | Long-term lapse rate (2) |  | 1 | % |  | - | 30 | % |
﻿ |  |  |  |  |  |  | Utilization of guaranteed withdrawals (3) | 85 | % |  | - | 100 | % |
﻿ |  |  |  |  |  |  | Claims utilization factor (4) |  | 60 | % |  | - | 100 | % |
﻿ |  |  |  |  |  |  | Premiums utilization factor (4) |  | 80 | % |  | - | 115 | % |
﻿ |  |  |  |  |  |  | NPR (5) |  | 0.01 | % |  | - | 0.27 | % |
﻿ |  |  |  |  |  |  | Mortality rate (6) |  |  |  |  |  | (8) |  |
﻿ |  |  |  |  |  |  | Volatility (7) |  | 1 | % |  | - | 29 | % |
﻿
| (1) |  | The liquidity/duration adjustment input represents an estimated market participant composite of adjustments attributable to liquidity premiums, expected durations, structures and credit quality that would be applied to the market observable information of an investment.
| (2) |  | The lapse rate input represents the estimated probability of a contract surrendering during a year, and thereby forgoing any future benefits. The range for indexed annuity and IUL contracts represents the lapse rates during the surrender charge period.
| (3) |  | The utilization of guaranteed withdrawals input represents the estimated percentage of contract holders that utilize the guaranteed withdrawal feature.
| (4) |  | The utilization factors are applied to the present value of claims or premiums, as appropriate, in the GLB reserve calculation to estimate the impact of inefficient withdrawal behavior, including taking less than or more than the maximum guaranteed withdrawal.
| (5) |  | The NPR input represents the estimated additional credit spread that market participants would apply to the market observable discount rate when pricing a contract.
| (6) |  | The mortality rate input represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.
| (7) |  | The volatility input represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Fair value of the variable annuity GLB embedded derivatives would increase if higher volatilities were used for valuation.
| (8) |  | The mortality rate is based on a combination of company and industry experience, adjusted for improvement factors.
From the table above, we have excluded Level 3 fair value measurements obtained from independent, third-party pricing sources. We do not develop the significant inputs used to measure the fair value of these assets and liabilities, and the information regarding the significant inputs is not readily available to us. Independent broker-quoted fair values are non-binding quotes developed by market makers or broker-dealers obtained from third-party sources recognized as market participants. The fair value of a broker-quoted asset or liability is based solely on the receipt of an updated quote from a single market maker or a broker-dealer recognized as a market participant as we do not adjust broker quotes when used as the fair value measurement for an asset or liability. Significant increases or decreases in any of the quotes received from a third-party broker-dealer may result in a significantly higher or lower fair value measurement. ﻿ Changes in any of the significant inputs presented in the table above may result in a significant change in the fair value measurement of the asset or liability as follows: ﻿
| · |  | Investments – An increase in the liquidity/duration adjustment input would result in a decrease in the fair value measurement.
| · |  | Indexed annuity and IUL contracts embedded derivatives – For direct embedded derivatives, a n increase in the lapse rate or mortality rate inputs would result in a decrease in the fair value measurement.
| · |  | GLB embedded derivatives – Assuming our GLB direct embedded derivative s are in a liability position, an increase in our lapse rate, NPR or mortality rate inputs would result in a decrease in the fair value measurement; and an increase in the utilization of guaranteed withdrawal or volatility inputs would result in an increase in the fair value measurement.
﻿ For each category discussed above, the unobservable inputs are not inter-related; therefore, a directional change in one input will not affect the other inputs. ﻿ As part of our ongoing valuation process, we assess the reasonable ness of our valuation techniques or models and make adjustments as necessary. For more information, see “Summary of Significant Accounting Policies” in Note 1 of our 2 016 Form 10-K.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -URI http://asc.fasb.org/topic&trid=2155941 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration